SUSTAINED EFFICACY IS ACHIEVED WITH REPEAT COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS (TNF-IR)

被引：0
|
作者：
Keystone, Edward C. [1 ]
Fleischmann, Roy M. [2 ]
Emery, Paul [3 ]
Dougados, Maxime [4 ]
Baldassare, Andrew R. [5 ]
Armstrong, Gillian K. [6 ]
Linnik, Matthew [7 ]
Reynard, Mark [6 ]
Tyrrell, Helen [6 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Leeds Gen Infirm, Leeds, W Yorkshire, England
[4] Hop Cochin, F-75674 Paris, France
[5] St Louis Univ, St Louis, MO 63103 USA
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[7] Biogen Idec Inc, San Diego, CA USA
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I98 / I98
页数：1
相关论文
共 50 条
  • [21] Inhibition of joint structural damage with rituximab is not dependant on clinical response in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (REFLEX study).
    Keystone, Edward
    Emery, Paul
    Peterfy, Charles G.
    Tak, Paul P.
    Cohen, Stanley B.
    Genovese, Mark C.
    Williams, Sarah
    Totoritis, Mark C.
    Cravets, Matt W.
    Shaw, Tim
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S542 - S543
  • [22] Prevention of joint structural damage at 1 year with rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (Reflex study)
    Keystone, E.
    Pope, J. E.
    Emery, P.
    Peterfy, C. G.
    Tak, P. P.
    Cohen, S.
    Genovese, M.
    Williams, S.
    Totoritis, M.
    Cravets, M.
    Shaw, T.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1619 - 1619
  • [23] Prevention of joint structural damage at 1 year with rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (reflex study)
    Keystone, E.
    Emery, P.
    Peterfy, C. G.
    Tak, P. P.
    Cohen, S.
    Genovese, M.
    Williams, S.
    Totoritis, M.
    Cravets, M.
    Shaw, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 58 - 58
  • [24] EFFICACY AND SAFETY OF REPEAT TREATMENT COURSES OF RITUXIMAB IN RA PATIENTS (PTS) WITH INADEQUATE RESPONSE (IR) TO TUMOUR NECROSIS FACTOR (TNF) INHIBITORS: LONG-TERM EXPERIENCE FROM THE REFLEX STUDY
    Keystone, Edward C.
    Fleischmann, Roy M.
    Emery, Paul
    Chubick, Andrew
    Dougados, Maxime R.
    Baldassare, Andrew R.
    Bathon, Joan M.
    Hessey, Eva W.
    Hagerty, David
    Safa-Leathers, Simon
    RHEUMATOLOGY, 2009, 48 : I65 - I66
  • [25] Sustained efficacy of repeat treatment courses of rituximab in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs
    Emery, P.
    Furst, D. E.
    Ferraccioli, G.
    Udell, J.
    van Vollenhoven, R. F.
    Rowe, K.
    Agarwal, S.
    Shaw, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 430 - 430
  • [26] Efficacy and Safety of Repeat Treatment Courses of Rituximab in RA Patients with Inadequate Response to Tumor Necrosis Factor (TNF) Inhibitors: Long-term Experience from the REFLEX Study
    Blocka, K.
    Keystone, E.
    Fleischmann, R. M.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2589 - 2589
  • [27] Improved clinical and simplified disease activity index (CDAI, SDAI) scores with rituximab in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors
    Smolen, Josef
    Cividino, Alfred
    Kavanugh, Arthur
    Tony, Hans Peter
    Greenwald, Maria
    De Vita, Salvatore
    Brasington, Richard
    Aletaha, Daniel
    White, Anne Marie
    Hessey, Eva
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1191 - 1191
  • [28] Repeat treatment with rituximab in active RA patients: Long-term efficacy in patients with one versus two or more prior TNF inhibitors
    Emery, Paul
    Kremer, Joel M.
    Tony, Hans P.
    Genovese, Mark C.
    Tak, Paul-Peter
    Luggen, Michael
    Bombardieri, Stefano
    Hessey, Eva
    Safa-Leathers, Simon
    RHEUMATOLOGY, 2008, 47 : II38 - II38
  • [29] Repeat treatment with rituximab inactive RA patients: Long-term efficacy in patients with one versus two or more prior TNF inhibitors
    Kremer, J. M.
    Tony, H. P.
    Genovese, M. C.
    Tak, P. P.
    Luggen, M.
    Bombardieri, S.
    Hessey, E.
    Safa-Leathers, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 432 - 433
  • [30] Joint structural damage prevention with rituximab in patients with rheumatoid arthritis and an inadequate response to one or more TNF inhibitors: 1 year data from the reflex study
    Keystone, E.
    Kvien, T. K.
    Emery, P.
    Peterfy, C. D.
    Tak, P. P.
    Cohen, S.
    Genovese, M.
    Williams, S.
    Totoritis, M.
    Cravets, M.
    Shaw, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 14 - 14
12345